FDA Inspection
Kite Pharma, Inc.Kite Pharma, Inc. – FDA Inspection, Nov 1, 2024
Record Details
This FDA Inspection record concerns Kite Pharma, Inc., with an inspection on November 1, 2024, issued by the Baltimore District Office, covering biologics.
View Company Profile
ID · 1356c91e-dcb6-455b-869d-a58969e2a431
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1253766
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 600.80(c)(1)(i)Reporting Requirements - 15-day alert
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.